Advertisement

Topics

FDA announces comprehensive regenerative medicine policy framework

04:22 EST 16 Nov 2017 | FDA

FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.

Original Article: FDA announces comprehensive regenerative medicine policy framework

NEXT ARTICLE

More From BioPortfolio on "FDA announces comprehensive regenerative medicine policy framework"

Advertisement
Quick Search
Advertisement
Advertisement